Berwyn-based AMETEK Announces Record Third Quarter Financial Results and Raises 2019 Guidance

Financial results

BERWYN, PA — AMETEK, Inc. (NYSE: AME) recently announced its financial results for the third quarter ended September 30, 2019.

AMETEK’s third quarter 2019 sales were $1.28 billion, up 7% compared to the third quarter of 2018. Operating income increased 13% to a record $301.1 million and operating margins were 23.6% in the quarter, an increase of 140 basis points over the prior year.

On a GAAP basis, third quarter earnings were $0.96 per diluted share. Adjusted earnings, which adds back non-cash, after-tax, acquisition-related intangible amortization, were $1.06 per diluted share, a 16% increase over the prior-year’s comparable quarter. A reconciliation of reported GAAP earnings to adjusted earnings is included in the financial tables accompanying this release and on the AMETEK website.

“AMETEK generated excellent results in the third quarter,” said David A. Zapico, AMETEK Chairman and Chief Executive Officer. “We delivered a 16% year-over-year increase in adjusted earnings on solid organic sales growth, contributions from recent acquisitions and exceptional operating performance.”

“Cash flow was again excellent, with record operating cash flow of $330 million in the quarter, a 33% increase over the same period last year. We continue to utilize our cash flow to support our strategic acquisition strategy, with nearly $1.1 billion deployed thus far in 2019 on the acquisitions of Gatan and Pacific Design Technologies.”

READ:  Vishay Intertechnology Lowers TCR for TNPU e3 Series Ultra Precision Thin Film Flat Chip Resistors in 0603, 0805, and 1206 Case Sizes

Electronic Instruments Group (EIG)
Sales for EIG in the third quarter were $815.6 million, up 10% compared to the third quarter of 2018. EIG operating income for the quarter increased 15% over the prior-year period to a record $219.5 million. Operating income margins were 26.9%, up 130 basis points over the prior year.

“EIG delivered strong results in the third quarter with impressive sales growth and outstanding operating performance,” noted Mr. Zapico. “Sales grew 10% on solid organic sales growth and contributions from the recent acquisitions of Forza, Telular and Spectro Scientific. EIG also continues to deliver impressive operating margin expansion through its Operational Excellence initiatives.”

Electromechanical Group (EMG)
EMG sales in the third quarter were $461.1 million, up 2% over the same quarter in 2018. Operating income increased 12% to $103.5 million, and operating income margins were 22.4%, up 180 basis points over the prior third quarter.

READ:  AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™

“EMG’s operating performance was also outstanding in the third quarter,” commented Mr. Zapico. “EMG delivered exceptional operating margin expansion on solid organic sales growth, contributions from the acquisition of Pacific Design Technologies and continued efficiency improvements.”

2019 Outlook
“Our businesses continue to perform exceedingly well by executing the AMETEK Growth Model. We remain focused on investing in our organic growth initiatives, driving continued cost and asset management improvements, and deploying our capital on strategic acquisitions to create long-term, sustainable value,” noted Mr. Zapico. “AMETEK’s results in the third quarter and through the first nine months of the year exemplify these efforts. Given these results, we have again raised our full-year earnings guidance.”

“For all of 2019, we expect overall sales to be up mid to high single digits on a percentage basis compared to 2018, with strong contributions from recent acquisitions and organic sales growth of approximately 3%. Adjusted earnings per diluted share are now expected to be in the range of $4.12 to $4.14, an increase of 13% over the prior year. This is an increase from our previous adjusted guidance range of $4.04 to $4.10 per diluted share,” he added.

READ:  Annovis Bio Issued European Patent for Method of Treating Alzheimer’s Disease with ANVS401

“Fourth quarter 2019 sales are expected to be up mid-single digits on a percentage basis compared to the same quarter in 2018. Adjusted earnings per diluted share are expected to be in the range of $1.01 to $1.03, up 5% to 7% compared to last year’s fourth quarter,” concluded Mr. Zapico.

Source: AMETEK, Inc., 1100 Cassatt Road, Berwyn PA 19312

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee